EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO
GLASGOW, Scotland, Feb. 01, 2024 (GLOBE NEWSWIRE) -- EnteroBiotix Limited (“EBX”), a clinical stage biopharmaceutical company with the premier platform...
Diagnostics
GE HealthCare Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation
Latest digital platform provides key advancements to help maintain high signal fidelity while reducing environmental noise Forward-looking platform designed to...
Study Unlocks New Hope in the Battle Against Male Infertility
A new study from UCLA and MicroGenDX shows that bacteria may be one of the factors holding back male fertilityORLANDO,...
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
STONY BROOK, NY / ACCESSWIRE / January 31, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in...
Open Letter to Zomedica Shareholders from your Chief Executive Officer
ANN ARBOR, MI / ACCESSWIRE / January 31, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Ocugen to Present at Pharma Market Research Conference
MALVERN, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
AlzeCure CEO Martin Jönsson to Present at the International Investor Conference BioCapitalEurope
STOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference
ANN ARBOR, MI / ACCESSWIRE / January 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
RevoluGen Demonstrates Superior Automated Magnetic Bead-Based HMW-DNA Extraction with its Fire Monkey Chemistry Under Collaboration with LGC Biosearch Technologies
HADFIELD, United Kingdom, Jan. 30, 2024 (GLOBE NEWSWIRE) -- UK genomics company, RevoluGen Ltd., has demonstrated a new protocol for...
Fitbit and Quest Diagnostics Collaborate To Advance Research on the Use of Wearable Devices To Improve Metabolic Health
Study to evaluate how behavioral and sensor data from wearables and blood tests can be leveraged to help individuals better...
Specialty-Driven Platforms Outperform Broad-Spectrum EHRs in Top 2024 Physician Satisfaction Ratings, 14th Annual Black Book Ambulatory Practice Surveys
Ninety-three percent of independent medical providers agree that specialist-specific EHRs position them best for value-based reimbursement, practice management and patient...
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
Science 37 stockholders to receive $5.75 per share in cashRESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science...
Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development
NEW YORK--(BUSINESS WIRE)--Deliberate AI, a digital health technology company that delivers precision measurement of mental health through AI, today announced...
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote “FOR” Proposed Reverse Stock Split
ANN ARBOR, MI / ACCESSWIRE / January 25, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the appointment of Dr. Vimal...
ReAlta Life Sciences Strengthens Board of Directors with Appointment of Two Accomplished Biotechnology Innovators
New appointments bring deep research and development expertise and technology innovation to support continued advancement of ReAlta’s EPICC Technology PlatformNORFOLK,...
nmible partners with Velocity Clinical Research to streamline clinical trials patient stipends
Velocity President and Chief Executive, Dr Paul Evans Velocity President and Chief Executive, Dr Paul Evans • nmible’s solution expected...
Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing
Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome mapping (OGM) that...
IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine
Board strengthened with appointments of Tim Haines (Abingworth) as Non-executive Chair and Dr Oliver Nussbaumer (co-founder of GammaDelta Therapeutics and...
Gilead Sciences: Art Captures the Experiences of Women Living With Metastatic Breast Cancer
NORTHAMPTON, MA / ACCESSWIRE / January 23, 2024 / For the past 30 years, Pilar Fernandez has navigated living with...